-
2
-
-
0036917726
-
An international comparison of tobacco smoking, beliefs and risk awareness in university students from 23 countries
-
Steptoe A., Wardle J., Cui W., Baban A., Glass K., Pelzer K., Tsuda A., and Vinck J. An international comparison of tobacco smoking, beliefs and risk awareness in university students from 23 countries. Addiction 97 (2002) 1561-1571
-
(2002)
Addiction
, vol.97
, pp. 1561-1571
-
-
Steptoe, A.1
Wardle, J.2
Cui, W.3
Baban, A.4
Glass, K.5
Pelzer, K.6
Tsuda, A.7
Vinck, J.8
-
3
-
-
10244226217
-
-
World Bank, Washington, DC (HNP discussion paper no. 6, Economics of tobacco control paper no. 6)
-
Guindon G.E., and Boisclair D. Past, Current and Future Trends in Tobacco Use (2003), World Bank, Washington, DC (HNP discussion paper no. 6, Economics of tobacco control paper no. 6)
-
(2003)
Past, Current and Future Trends in Tobacco Use
-
-
Guindon, G.E.1
Boisclair, D.2
-
4
-
-
67649379992
-
-
World Health Organization. The World Health Report 2003-Shaping the Future, 2003
-
World Health Organization. The World Health Report 2003-Shaping the Future, 2003.
-
-
-
-
5
-
-
34250648075
-
Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking
-
Mucha L., Stephenson J., Morandi N., and Dirani R. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend. Med. 3 (2006) 279-291
-
(2006)
Gend. Med.
, vol.3
, pp. 279-291
-
-
Mucha, L.1
Stephenson, J.2
Morandi, N.3
Dirani, R.4
-
6
-
-
0141741729
-
Estimates of global mortality attributable to smoking in 2000
-
Ezzati M., and Lopez A.D. Estimates of global mortality attributable to smoking in 2000. Lancet 362 (2003) 847-852
-
(2003)
Lancet
, vol.362
, pp. 847-852
-
-
Ezzati, M.1
Lopez, A.D.2
-
8
-
-
0020450943
-
Cigarette smoking and alcohol use in Finland and Sweden: a cross-national twin study
-
Kaprio J., Hammar N., Koskenvuo M., Floderus-Myrhed B., Langinvainio H., and Sarna S. Cigarette smoking and alcohol use in Finland and Sweden: a cross-national twin study. Int. J. Epidemiol. 11 (1982) 378-386
-
(1982)
Int. J. Epidemiol.
, vol.11
, pp. 378-386
-
-
Kaprio, J.1
Hammar, N.2
Koskenvuo, M.3
Floderus-Myrhed, B.4
Langinvainio, H.5
Sarna, S.6
-
9
-
-
0027767326
-
Genetic contributions to risk of smoking initiation: comparisons across birth cohorts and across cultures
-
Heath A.C., Cates R., Martin N.G., Meyer J., Hewitt J.K., Neale M.C., and Eaves L.J. Genetic contributions to risk of smoking initiation: comparisons across birth cohorts and across cultures. J. Subst. Abuse 5 (1993) 221-246
-
(1993)
J. Subst. Abuse
, vol.5
, pp. 221-246
-
-
Heath, A.C.1
Cates, R.2
Martin, N.G.3
Meyer, J.4
Hewitt, J.K.5
Neale, M.C.6
Eaves, L.J.7
-
10
-
-
0027478680
-
Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence
-
Heath A.C., and Martin N.G. Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. Addict. Behav. 16 (1993) 19-34
-
(1993)
Addict. Behav.
, vol.16
, pp. 19-34
-
-
Heath, A.C.1
Martin, N.G.2
-
11
-
-
0030728963
-
Genetic and environmental contributions to smoking
-
True W.R., Heath A.C., Scherrer J.F., Waterman B., Goldberg J., Lin N., Eisen S.A., Lyons M.J., and Tsuang M.T. Genetic and environmental contributions to smoking. Addiction 92 (1997) 1277-1287
-
(1997)
Addiction
, vol.92
, pp. 1277-1287
-
-
True, W.R.1
Heath, A.C.2
Scherrer, J.F.3
Waterman, B.4
Goldberg, J.5
Lin, N.6
Eisen, S.A.7
Lyons, M.J.8
Tsuang, M.T.9
-
12
-
-
0032990447
-
A population-based twin study in women of smoking initiation and nicotine dependence
-
Kendler K.S., Neale M.C., Sullivan P., Corey L.A., Gardner C.O., and Prescott C.A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol. Med. 29 (1999) 299-308
-
(1999)
Psychol. Med.
, vol.29
, pp. 299-308
-
-
Kendler, K.S.1
Neale, M.C.2
Sullivan, P.3
Corey, L.A.4
Gardner, C.O.5
Prescott, C.A.6
-
14
-
-
0038215626
-
The genetic determinants of smoking
-
Batra V., Patkar A.A., Berrettini W.H., Weinstein S.P., and Leone F.T. The genetic determinants of smoking. Chest 123 (2003) 1730-1739
-
(2003)
Chest
, vol.123
, pp. 1730-1739
-
-
Batra, V.1
Patkar, A.A.2
Berrettini, W.H.3
Weinstein, S.P.4
Leone, F.T.5
-
15
-
-
0032978705
-
Common genetic vulnerability for nicotine and alcohol dependence in men
-
True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., Eisen S.A., Lyons M.J., Goldberg J., and Tsuang M. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch. Gen. Psychiatry 56 (1999) 655-661
-
(1999)
Arch. Gen. Psychiatry
, vol.56
, pp. 655-661
-
-
True, W.R.1
Xian, H.2
Scherrer, J.F.3
Madden, P.A.4
Bucholz, K.K.5
Heath, A.C.6
Eisen, S.A.7
Lyons, M.J.8
Goldberg, J.9
Tsuang, M.10
-
16
-
-
0038036814
-
The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit
-
Xian H., Scherrer J.F., Madden P.A., Lyons M.J., Tsuang M., True W.R., and Eisen S.A. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob. Res. 5 (2003) 245-254
-
(2003)
Nicotine Tob. Res.
, vol.5
, pp. 245-254
-
-
Xian, H.1
Scherrer, J.F.2
Madden, P.A.3
Lyons, M.J.4
Tsuang, M.5
True, W.R.6
Eisen, S.A.7
-
17
-
-
0032947801
-
Susceptibility genes for nicotine dependence: a genome scan and follow-up in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit furhter study
-
Straub R.E., Sullivan P.F., Ma Y., Myakishev M.V., Harris-Kerr C., Wormley B., Kadambi B., Sadek H., Silverman M.A., Webb B.T., Neale M.C., Bulik C.M., Joyce P.R., and Kendler K.S. Susceptibility genes for nicotine dependence: a genome scan and follow-up in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit furhter study. Mol. Psychiatry 4 (1999) 129-1244
-
(1999)
Mol. Psychiatry
, vol.4
, pp. 129-1244
-
-
Straub, R.E.1
Sullivan, P.F.2
Ma, Y.3
Myakishev, M.V.4
Harris-Kerr, C.5
Wormley, B.6
Kadambi, B.7
Sadek, H.8
Silverman, M.A.9
Webb, B.T.10
Neale, M.C.11
Bulik, C.M.12
Joyce, P.R.13
Kendler, K.S.14
-
18
-
-
0032710004
-
Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q
-
Duggirala R., Almasy L., and Blangero J. Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. Genet. Epidemiol. 17 (1999) 139-144
-
(1999)
Genet. Epidemiol.
, vol.17
, pp. 139-144
-
-
Duggirala, R.1
Almasy, L.2
Blangero, J.3
-
19
-
-
84872256320
-
Multiple genome-wide analyses of smoking behavior in the Framingham Hearth Study
-
Framingham Heart Study
-
Goode E.L., Badzioch M.D., Kim H., Gagnon F., Rozek L.S., Edwards K.L., Jarvik G.P., and Framingham Heart Study. Multiple genome-wide analyses of smoking behavior in the Framingham Hearth Study. BMC Genet. 4 (2003) S102
-
(2003)
BMC Genet.
, vol.4
-
-
Goode, E.L.1
Badzioch, M.D.2
Kim, H.3
Gagnon, F.4
Rozek, L.S.5
Edwards, K.L.6
Jarvik, G.P.7
-
21
-
-
1842435105
-
Candidate genes for nicotine dependence via linkage, epistasis and bioinformatics
-
Sullivan P.F., Neale B.M., van den Oord E., Miles M.F., Neale M.C., Bulik C.M., Joyce P.R., Straub R.E., and Kendler K.S. Candidate genes for nicotine dependence via linkage, epistasis and bioinformatics. Am. J. Med. Genet. 126B (2004) 23-36
-
(2004)
Am. J. Med. Genet.
, vol.126 B
, pp. 23-36
-
-
Sullivan, P.F.1
Neale, B.M.2
van den Oord, E.3
Miles, M.F.4
Neale, M.C.5
Bulik, C.M.6
Joyce, P.R.7
Straub, R.E.8
Kendler, K.S.9
-
22
-
-
3042806901
-
Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking
-
Gelernter J., Liu X., Hesselbrock V., Page G.P., Goddard A., and Zhang H. Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking. Am. J. Med. Genet. 128B (2004) 94-101
-
(2004)
Am. J. Med. Genet.
, vol.128 B
, pp. 94-101
-
-
Gelernter, J.1
Liu, X.2
Hesselbrock, V.3
Page, G.P.4
Goddard, A.5
Zhang, H.6
-
23
-
-
33644609748
-
Genomic screen for loci associated with tobacco usage in Mission Indians
-
Ehlers C.L., and Wilhelmsen K.C. Genomic screen for loci associated with tobacco usage in Mission Indians. BMC Med. Genet. 7 (2006) 9
-
(2006)
BMC Med. Genet.
, vol.7
, pp. 9
-
-
Ehlers, C.L.1
Wilhelmsen, K.C.2
-
24
-
-
33745033392
-
A genome-wide screen for nicotine dependence susceptibility loci
-
Swan G.E., Hops H., Wilhelmsen K.C., Lessov-Schlaggar C.N., Cheng L.S., Hudmon K.S., Amos C.I., Feiler H.S., Ring H.Z., Andrews J.A., Tildesley E., and Benowitz N. A genome-wide screen for nicotine dependence susceptibility loci. Am. J. Med. 141B (2006) 354-360
-
(2006)
Am. J. Med.
, vol.141 B
, pp. 354-360
-
-
Swan, G.E.1
Hops, H.2
Wilhelmsen, K.C.3
Lessov-Schlaggar, C.N.4
Cheng, L.S.5
Hudmon, K.S.6
Amos, C.I.7
Feiler, H.S.8
Ring, H.Z.9
Andrews, J.A.10
Tildesley, E.11
Benowitz, N.12
-
25
-
-
33845202242
-
Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus
-
Gelernter J., Panhuysen C., Weiss R., Brady K., Poling J., Krauthammer M., Farrer L., and Kranzler H.R. Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus. Biol. Psychiatry 61 (2007) 119-126
-
(2007)
Biol. Psychiatry
, vol.61
, pp. 119-126
-
-
Gelernter, J.1
Panhuysen, C.2
Weiss, R.3
Brady, K.4
Poling, J.5
Krauthammer, M.6
Farrer, L.7
Kranzler, H.R.8
-
26
-
-
33846536406
-
Novel genes identified in a high-density genome wide association study for nicotine dependence
-
Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., Swan G.E., Rutter J., Bertelsen S., Fox L., Fugman D., Goate A.M., Hinrichs A.L., Konvicka K., Martin N.G., Montgomery G.W., Saccone N.L., Saccone S.F., Wang J.C., Chase G.A., Rice J.P., and Ballinger D.G. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16 (2007) 24-35
-
(2007)
Hum. Mol. Genet.
, vol.16
, pp. 24-35
-
-
Bierut, L.J.1
Madden, P.A.2
Breslau, N.3
Johnson, E.O.4
Hatsukami, D.5
Pomerleau, O.F.6
Swan, G.E.7
Rutter, J.8
Bertelsen, S.9
Fox, L.10
Fugman, D.11
Goate, A.M.12
Hinrichs, A.L.13
Konvicka, K.14
Martin, N.G.15
Montgomery, G.W.16
Saccone, N.L.17
Saccone, S.F.18
Wang, J.C.19
Chase, G.A.20
Rice, J.P.21
Ballinger, D.G.22
more..
-
27
-
-
34247327670
-
Molecular genetics of nioctine dependence and abstinence: whole genome association using 520,000 SNPs
-
Ulh G.R., Liu Q.R., Drgon T., Johnson C., Walther D., and Rose J.E. Molecular genetics of nioctine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet. 8 (2007) 10
-
(2007)
BMC Genet.
, vol.8
, pp. 10
-
-
Ulh, G.R.1
Liu, Q.R.2
Drgon, T.3
Johnson, C.4
Walther, D.5
Rose, J.E.6
-
28
-
-
0032565878
-
Nicotine metabolism defect reduces smoking [letter]
-
Pianezza M.L., Sellers E.M., and Tyndale R.F. Nicotine metabolism defect reduces smoking [letter]. Nature 393 (1998) 750
-
(1998)
Nature
, vol.393
, pp. 750
-
-
Pianezza, M.L.1
Sellers, E.M.2
Tyndale, R.F.3
-
29
-
-
0033807421
-
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking
-
Rao Y., Hoffmann E., Zia M., Bodin L., Zeman M., Sellers E.M., and Tyndale R.F. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol. Pharmacol. 58 (2000) 747-755
-
(2000)
Mol. Pharmacol.
, vol.58
, pp. 747-755
-
-
Rao, Y.1
Hoffmann, E.2
Zia, M.3
Bodin, L.4
Zeman, M.5
Sellers, E.M.6
Tyndale, R.F.7
-
30
-
-
0035064372
-
Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk
-
Tyndale R.F., and Sellers E.M. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab. Dispos. 29 (2001) 548-552
-
(2001)
Drug Metab. Dispos.
, vol.29
, pp. 548-552
-
-
Tyndale, R.F.1
Sellers, E.M.2
-
31
-
-
0038348799
-
Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults
-
Ando M., Hamajima N., Ariyoshi N., Kamataki T., Matsuo K., and Ohno Y. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. J. Epidemiol. 13 (2003) 176-181
-
(2003)
J. Epidemiol.
, vol.13
, pp. 176-181
-
-
Ando, M.1
Hamajima, N.2
Ariyoshi, N.3
Kamataki, T.4
Matsuo, K.5
Ohno, Y.6
-
32
-
-
10344238546
-
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers
-
Fujieda M., Yamazaki H., Saito T., Kiyotani K., Gyamfi M.A., Sakurai M., Dosaka-Akita H., Sawamura Y., Yokota J., Kunitoh H., and Kamataki T. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 25 (2004) 2451-2458
-
(2004)
Carcinogenesis
, vol.25
, pp. 2451-2458
-
-
Fujieda, M.1
Yamazaki, H.2
Saito, T.3
Kiyotani, K.4
Gyamfi, M.A.5
Sakurai, M.6
Dosaka-Akita, H.7
Sawamura, Y.8
Yokota, J.9
Kunitoh, H.10
Kamataki, T.11
-
33
-
-
4644255903
-
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians
-
Schoedel K.A., Hoffmann E.B., Rao Y., Sellers E.M., and Tyndale R.F. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 14 (2004) 615-626
-
(2004)
Pharmacogenetics
, vol.14
, pp. 615-626
-
-
Schoedel, K.A.1
Hoffmann, E.B.2
Rao, Y.3
Sellers, E.M.4
Tyndale, R.F.5
-
34
-
-
0033550994
-
Genetic variation of CYP2A6, smoking, and risk of cancer
-
London S.J., Idle J.R., Daly A.K., and Coetzee G.A. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353 (1999) 898-899
-
(1999)
Lancet
, vol.353
, pp. 898-899
-
-
London, S.J.1
Idle, J.R.2
Daly, A.K.3
Coetzee, G.A.4
-
35
-
-
17744381734
-
Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population
-
Loriot M.A., Rebuissou S., Oscarson M., Cenee S., Miyamoto M., Ariyoshi N., Kamataki T., Hémon D., Beaune P., and Stücker I. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics 11 (2001) 39-44
-
(2001)
Pharmacogenetics
, vol.11
, pp. 39-44
-
-
Loriot, M.A.1
Rebuissou, S.2
Oscarson, M.3
Cenee, S.4
Miyamoto, M.5
Ariyoshi, N.6
Kamataki, T.7
Hémon, D.8
Beaune, P.9
Stücker, I.10
-
36
-
-
2542503580
-
A meta-analytic review of the CYP2A6 genotype and smoking behavior
-
Carter B., Long T., and Cinciripini P. A meta-analytic review of the CYP2A6 genotype and smoking behavior. Nicotine Tob. Res. 6 (2004) 221-227
-
(2004)
Nicotine Tob. Res.
, vol.6
, pp. 221-227
-
-
Carter, B.1
Long, T.2
Cinciripini, P.3
-
37
-
-
0034091750
-
CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour
-
Saarikoski S.T., Sata F., Husgafvel-Pursiainen K., Rautalahti M., Haukka J., Impivaara O., Järvisalo J., Vainio H., and Hirvonen A. CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. Pharmacogenetics 10 (2000) 5-10
-
(2000)
Pharmacogenetics
, vol.10
, pp. 5-10
-
-
Saarikoski, S.T.1
Sata, F.2
Husgafvel-Pursiainen, K.3
Rautalahti, M.4
Haukka, J.5
Impivaara, O.6
Järvisalo, J.7
Vainio, H.8
Hirvonen, A.9
-
38
-
-
0029947583
-
CYP2D6 genotypes in cigarette smokers and non-tobacco users
-
Cholerton S., Boustead C., Taber H., Arpanahi A., and Idle J.R. CYP2D6 genotypes in cigarette smokers and non-tobacco users. Pharmacogenetics 6 (1996) 261-263
-
(1996)
Pharmacogenetics
, vol.6
, pp. 261-263
-
-
Cholerton, S.1
Boustead, C.2
Taber, H.3
Arpanahi, A.4
Idle, J.R.5
-
40
-
-
3042635325
-
A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men
-
Feng Y., Niu T., Xing H., Xu X., Chen C., Peng S., Wang L., Laird N., and Xu X. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am. J. Hum. Genet. 75 (2004) 112-121
-
(2004)
Am. J. Hum. Genet.
, vol.75
, pp. 112-121
-
-
Feng, Y.1
Niu, T.2
Xing, H.3
Xu, X.4
Chen, C.5
Peng, S.6
Wang, L.7
Laird, N.8
Xu, X.9
-
41
-
-
18144427933
-
Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence
-
Li M.D., Beuten J., Ma J.Z., Payne T.J., Lou X.Y., Garcia V., Duenes A.S., Crews K.M., and Elston R.C. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum. Mol. Genet. 14 (2005) 1211-1219
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 1211-1219
-
-
Li, M.D.1
Beuten, J.2
Ma, J.Z.3
Payne, T.J.4
Lou, X.Y.5
Garcia, V.6
Duenes, A.S.7
Crews, K.M.8
Elston, R.C.9
-
42
-
-
34447551688
-
Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine
-
Ehringer M.A., Clegg H.V., Collins A.C., Corley R.P., Crowley T., Hewitt J.K., Hopfer C.J., Krauter K., Lessem J., Rhee S.H., Schlaepfer I., Smolen A., Stallings M.C., Young S.E., and Zeiger J.S. Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am. J. Med. Genet. 144 (2007) 596-604
-
(2007)
Am. J. Med. Genet.
, vol.144
, pp. 596-604
-
-
Ehringer, M.A.1
Clegg, H.V.2
Collins, A.C.3
Corley, R.P.4
Crowley, T.5
Hewitt, J.K.6
Hopfer, C.J.7
Krauter, K.8
Lessem, J.9
Rhee, S.H.10
Schlaepfer, I.11
Smolen, A.12
Stallings, M.C.13
Young, S.E.14
Zeiger, J.S.15
-
43
-
-
37049014504
-
Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia
-
Voineskos S., De Luca V., Mensah A., Vincent J.B., Potapova N., and Kennedy J.L. Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. J. Psychiatry Neurosci. 32 (2007) 412-416
-
(2007)
J. Psychiatry Neurosci.
, vol.32
, pp. 412-416
-
-
Voineskos, S.1
De Luca, V.2
Mensah, A.3
Vincent, J.B.4
Potapova, N.5
Kennedy, J.L.6
-
44
-
-
33846510020
-
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs
-
Saccone S.F., Hinrichs A.L., Saccone N.L., Chase G.A., Konvicka K., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O., Swan G.E., Goate A.M., Rutter J., Bertelsen S., Fox L., Fugman D., Martin N.G., Montgomery G.W., Wang J.C., Ballinger D.G., Rice J.P., and Bierut L.J. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16 (2007) 36-49
-
(2007)
Hum. Mol. Genet.
, vol.16
, pp. 36-49
-
-
Saccone, S.F.1
Hinrichs, A.L.2
Saccone, N.L.3
Chase, G.A.4
Konvicka, K.5
Madden, P.A.6
Breslau, N.7
Johnson, E.O.8
Hatsukami, D.9
Pomerleau, O.10
Swan, G.E.11
Goate, A.M.12
Rutter, J.13
Bertelsen, S.14
Fox, L.15
Fugman, D.16
Martin, N.G.17
Montgomery, G.W.18
Wang, J.C.19
Ballinger, D.G.20
Rice, J.P.21
Bierut, L.J.22
more..
-
45
-
-
4043079375
-
Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia
-
De Luca V., Wang H., Squassina A., Wong G.W., Yeomans J., and Kennedy J.L. Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia. Neuropsychobiology 50 (2004) 124-127
-
(2004)
Neuropsychobiology
, vol.50
, pp. 124-127
-
-
De Luca, V.1
Wang, H.2
Squassina, A.3
Wong, G.W.4
Yeomans, J.5
Kennedy, J.L.6
-
46
-
-
33748741101
-
Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence
-
Lou X.Y., Ma J.Z., Payne T.J., Beuten J., Crew K.M., and Li M.D. Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence. Hum. Genet. 120 (2006) 381-389
-
(2006)
Hum. Genet.
, vol.120
, pp. 381-389
-
-
Lou, X.Y.1
Ma, J.Z.2
Payne, T.J.3
Beuten, J.4
Crew, K.M.5
Li, M.D.6
-
47
-
-
0034626404
-
Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence
-
Silverman M., Neale M., Sullivan P., Harris-Kerr C., Wormley B., Sadek H., Ma Y., Kendler K.S., and Straub R.E. Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. Am. J. Med. Genet. 96 (2000) 646-653
-
(2000)
Am. J. Med. Genet.
, vol.96
, pp. 646-653
-
-
Silverman, M.1
Neale, M.2
Sullivan, P.3
Harris-Kerr, C.4
Wormley, B.5
Sadek, H.6
Ma, Y.7
Kendler, K.S.8
Straub, R.E.9
-
48
-
-
33748282547
-
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers
-
Staley J.K., Krishnan-Sarin S., Cosgrove K.P., Krantzler E., Frohlich E., Perry E., Dubin J.A., Estok K., Brenner E., Baldwin R.M., Tamagnan G.D., Seibyl J.P., Jatlow P., Picciotto M.R., London E.D., O'Malley S., and van Dyck C.H. Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J. Neurosci. 26 (2006) 8707-8714
-
(2006)
J. Neurosci.
, vol.26
, pp. 8707-8714
-
-
Staley, J.K.1
Krishnan-Sarin, S.2
Cosgrove, K.P.3
Krantzler, E.4
Frohlich, E.5
Perry, E.6
Dubin, J.A.7
Estok, K.8
Brenner, E.9
Baldwin, R.M.10
Tamagnan, G.D.11
Seibyl, J.P.12
Jatlow, P.13
Picciotto, M.R.14
London, E.D.15
O'Malley, S.16
van Dyck, C.H.17
-
49
-
-
0028182216
-
D2 dopamine receptor gene and cigarette smoking: a reward gene?
-
Noble E., St Jeor S., Ritchie T., Syndulko K., St Jeor S., Fitch R., Brunner R.L., and Sparkes R.S. D2 dopamine receptor gene and cigarette smoking: a reward gene?. Med. Hypotheses 42 (1994) 257-260
-
(1994)
Med. Hypotheses
, vol.42
, pp. 257-260
-
-
Noble, E.1
St Jeor, S.2
Ritchie, T.3
Syndulko, K.4
St Jeor, S.5
Fitch, R.6
Brunner, R.L.7
Sparkes, R.S.8
-
50
-
-
0029665628
-
The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking
-
Comings D., Ferry L., Bradshaw-Robinson S., Burchette R., Chiu C., and Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 6 (1996) 73-79
-
(1996)
Pharmacogenetics
, vol.6
, pp. 73-79
-
-
Comings, D.1
Ferry, L.2
Bradshaw-Robinson, S.3
Burchette, R.4
Chiu, C.5
Muhleman, D.6
-
51
-
-
8244228682
-
Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors
-
Comings D.E., Gade R., Wu S., Chiu C., Dietz G., Muhleman D., Saucier G., Ferry L., Rosenthal R.J., Lesieur H.R., Rugle L.J., and MacMurray P. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol. Psychiatry 2 (1997) 44-56
-
(1997)
Mol. Psychiatry
, vol.2
, pp. 44-56
-
-
Comings, D.E.1
Gade, R.2
Wu, S.3
Chiu, C.4
Dietz, G.5
Muhleman, D.6
Saucier, G.7
Ferry, L.8
Rosenthal, R.J.9
Lesieur, H.R.10
Rugle, L.J.11
MacMurray, P.12
-
52
-
-
0031879906
-
Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians
-
Shields P.G., Lerman C., Audrain J., Bowman E.D., Main D., Boyd N.R., and Caporaso N.E. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 453-458
-
(1998)
Cancer Epidemiol. Biomarkers Prev.
, vol.7
, pp. 453-458
-
-
Shields, P.G.1
Lerman, C.2
Audrain, J.3
Bowman, E.D.4
Main, D.5
Boyd, N.R.6
Caporaso, N.E.7
-
53
-
-
0032481666
-
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients
-
Spitz M., Shi H., Yang F., Hudmon K., Jiang H., Chamberlain R., Amos C.I., Wan Y., Cinciripini P., Hong W.K., and Wu X. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J. Natl. Cancer Inst. 90 (1998) 358-363
-
(1998)
J. Natl. Cancer Inst.
, vol.90
, pp. 358-363
-
-
Spitz, M.1
Shi, H.2
Yang, F.3
Hudmon, K.4
Jiang, H.5
Chamberlain, R.6
Amos, C.I.7
Wan, Y.8
Cinciripini, P.9
Hong, W.K.10
Wu, X.11
-
54
-
-
0033626548
-
D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study
-
Wu X., Hudmon K.S., Detry M.A., Chamberlain R.M., and Spitz M.R. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1021-1026
-
(2000)
Cancer Epidemiol. Biomarkers Prev.
, vol.9
, pp. 1021-1026
-
-
Wu, X.1
Hudmon, K.S.2
Detry, M.A.3
Chamberlain, R.M.4
Spitz, M.R.5
-
55
-
-
0035826477
-
An association study of DRD5 with smoking initiation and progression to nicotine dependence
-
Sullivan P.F., Neale M.C., Silverman M.A., Harris-Kerr C., Myakishev M.V., Wormley B., Webb B.T., Ma Y., Kendler K.S., and Straub R.E. An association study of DRD5 with smoking initiation and progression to nicotine dependence. Am. J. Med. Genet. 105 (2001) 259-265
-
(2001)
Am. J. Med. Genet.
, vol.105
, pp. 259-265
-
-
Sullivan, P.F.1
Neale, M.C.2
Silverman, M.A.3
Harris-Kerr, C.4
Myakishev, M.V.5
Wormley, B.6
Webb, B.T.7
Ma, Y.8
Kendler, K.S.9
Straub, R.E.10
-
56
-
-
0034894354
-
Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese
-
Yoshida K., Hamajima N., Kozaki K., Saito H., Maeno K., Sugiura T., Ookuma K., and Takahashi T. Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 403-405
-
(2001)
Cancer Epidemiol. Biomarkers Prev.
, vol.10
, pp. 403-405
-
-
Yoshida, K.1
Hamajima, N.2
Kozaki, K.3
Saito, H.4
Maeno, K.5
Sugiura, T.6
Ookuma, K.7
Takahashi, T.8
-
57
-
-
4544328497
-
The genetic basis for smoking behavior: a systematic review and meta-analysis
-
Munafo M.R., Clark T.G., Johnstone E.C., Murphy M.F.G., and Walton R.T. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob. Res. 6 (2004) 583-597
-
(2004)
Nicotine Tob. Res.
, vol.6
, pp. 583-597
-
-
Munafo, M.R.1
Clark, T.G.2
Johnstone, E.C.3
Murphy, M.F.G.4
Walton, R.T.5
-
58
-
-
17644402792
-
Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?
-
Laucht M., Becker K., El-Faddagh M., Hohm E., and Schmidt M.H. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?. J. Am. Acad. Child. Adolesc. Psychiatry 44 (2005) 477-484
-
(2005)
J. Am. Acad. Child. Adolesc. Psychiatry
, vol.44
, pp. 477-484
-
-
Laucht, M.1
Becker, K.2
El-Faddagh, M.3
Hohm, E.4
Schmidt, M.H.5
-
59
-
-
0034723044
-
Polymorphisms in genes involved in neurotransmission in relation to smoking
-
Arinami T., Ishiguro H., and Onaivi E. Polymorphisms in genes involved in neurotransmission in relation to smoking. Eur. J. Pharmacol. 410 (2000) 215-226
-
(2000)
Eur. J. Pharmacol.
, vol.410
, pp. 215-226
-
-
Arinami, T.1
Ishiguro, H.2
Onaivi, E.3
-
60
-
-
0033971228
-
Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking
-
Bierut L., Rice J., Edenberg H., Goate A., Foroud T., Cloninger C., Begleiter H., Conneally P.M., Crowe R.R., Hesselbrock V., Li T.K., Nurnberger Jr. J.I., Porjesz B., Schuckit M.A., and Reich T. Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am. J. Med. Genet. 90 (2000) 299-302
-
(2000)
Am. J. Med. Genet.
, vol.90
, pp. 299-302
-
-
Bierut, L.1
Rice, J.2
Edenberg, H.3
Goate, A.4
Foroud, T.5
Cloninger, C.6
Begleiter, H.7
Conneally, P.M.8
Crowe, R.R.9
Hesselbrock, V.10
Li, T.K.11
Nurnberger Jr., J.I.12
Porjesz, B.13
Schuckit, M.A.14
Reich, T.15
-
61
-
-
8544229903
-
The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population
-
Johnstone E.C., Yudkin P., Griffiths S.E., Fuller A., Murphy M., and Walton R. The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. Addict. Biol. 9 (2004) 221-226
-
(2004)
Addict. Biol.
, vol.9
, pp. 221-226
-
-
Johnstone, E.C.1
Yudkin, P.2
Griffiths, S.E.3
Fuller, A.4
Murphy, M.5
Walton, R.6
-
62
-
-
0031979630
-
Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population
-
Singleton A.B., Thomson J.H., Morris C.M., Court J.A., Lloyd S., and Cholerton S. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics 8 (1998) 125-128
-
(1998)
Pharmacogenetics
, vol.8
, pp. 125-128
-
-
Singleton, A.B.1
Thomson, J.H.2
Morris, C.M.3
Court, J.A.4
Lloyd, S.5
Cholerton, S.6
-
63
-
-
0032930292
-
Evidence suggesting the role of specific genetic factors in cigarette smoking
-
Lerman C., Caporaso N.E., Audrain J., Main D., Bowman E.D., Lockshin B., Boyd N.R., and Shields P.G. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 18 (1999) 14-20
-
(1999)
Health Psychol.
, vol.18
, pp. 14-20
-
-
Lerman, C.1
Caporaso, N.E.2
Audrain, J.3
Main, D.4
Bowman, E.D.5
Lockshin, B.6
Boyd, N.R.7
Shields, P.G.8
-
64
-
-
0032958815
-
A genetic association for cigarette smoking behavior
-
Sabol S.Z., Nelson M.L., Fisher C., Gunzerath L., Brody C.L., Hu S., Sirota L.A., Marcus S.E., Greenberg B.D., Lucas IV F.R., Benjamin J., Murphy D.L., and Hamer D.H. A genetic association for cigarette smoking behavior. Health Psychol. 18 (1999) 7-13
-
(1999)
Health Psychol.
, vol.18
, pp. 7-13
-
-
Sabol, S.Z.1
Nelson, M.L.2
Fisher, C.3
Gunzerath, L.4
Brody, C.L.5
Hu, S.6
Sirota, L.A.7
Marcus, S.E.8
Greenberg, B.D.9
Lucas IV, F.R.10
Benjamin, J.11
Murphy, D.L.12
Hamer, D.H.13
-
65
-
-
7644242817
-
Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms
-
Erblich J., Lerman C., Self D.W., Diaz G.A., and Bovbjerg D.H. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J. 4 (2004) 102-109
-
(2004)
Pharmacogenomics J.
, vol.4
, pp. 102-109
-
-
Erblich, J.1
Lerman, C.2
Self, D.W.3
Diaz, G.A.4
Bovbjerg, D.H.5
-
66
-
-
0034640707
-
Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey
-
Jorm A.F., Henderson A.S., Jacomb P.A., Christensen H., Korten A.E., Rodgers B., Tan X., and Easteal S. Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. Am. J. Med. Genet. 96 (2000) 331-334
-
(2000)
Am. J. Med. Genet.
, vol.96
, pp. 331-334
-
-
Jorm, A.F.1
Henderson, A.S.2
Jacomb, P.A.3
Christensen, H.4
Korten, A.E.5
Rodgers, B.6
Tan, X.7
Easteal, S.8
-
67
-
-
0036670080
-
Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different
-
Vandenbergh D.J., Bennett C.J., Grant M.D., Strasser A.A., O'Connor R., Stauffer R.L., Vogler G.P., and Kozlowski L.T. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Nicotine Tob. Res. 4 (2002) 333-340
-
(2002)
Nicotine Tob. Res.
, vol.4
, pp. 333-340
-
-
Vandenbergh, D.J.1
Bennett, C.J.2
Grant, M.D.3
Strasser, A.A.4
O'Connor, R.5
Stauffer, R.L.6
Vogler, G.P.7
Kozlowski, L.T.8
-
68
-
-
1342330617
-
Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism
-
Anney R.J., Olsson C.A., Lotfi-Miri M., Patton G.C., and Williamson R. Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism. Pharmacogenetics 14 (2004) 73-81
-
(2004)
Pharmacogenetics
, vol.14
, pp. 73-81
-
-
Anney, R.J.1
Olsson, C.A.2
Lotfi-Miri, M.3
Patton, G.C.4
Williamson, R.5
-
69
-
-
0030666918
-
Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking
-
Lerman C., Shields P.G., Main D., Audrain J., Roth J., Boyd N.R., and Caporaso N.E. Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking. Pharmacogenetics 7 (1997) 521-524
-
(1997)
Pharmacogenetics
, vol.7
, pp. 521-524
-
-
Lerman, C.1
Shields, P.G.2
Main, D.3
Audrain, J.4
Roth, J.5
Boyd, N.R.6
Caporaso, N.E.7
-
70
-
-
0033816359
-
Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers
-
McKinney E.F., Walton R.T., Yudkin P., Fuller A., Haldar N.A., Mant D., Murphy M., Welsh K.I., and Marshall S.E. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 10 (2000) 483-491
-
(2000)
Pharmacogenetics
, vol.10
, pp. 483-491
-
-
McKinney, E.F.1
Walton, R.T.2
Yudkin, P.3
Fuller, A.4
Haldar, N.A.5
Mant, D.6
Murphy, M.7
Welsh, K.I.8
Marshall, S.E.9
-
71
-
-
0942279610
-
Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health
-
Olsson C., Anney R., Forrest S., Patton G., Coffey C., Cameron T., Hassett A., and Williamson R. Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health. Behav. Genet. 34 (2004) 85-91
-
(2004)
Behav. Genet.
, vol.34
, pp. 85-91
-
-
Olsson, C.1
Anney, R.2
Forrest, S.3
Patton, G.4
Coffey, C.5
Cameron, T.6
Hassett, A.7
Williamson, R.8
-
72
-
-
21844456618
-
Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men
-
Costa-Mallen P., Costa L.G., and Checkoway H. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men. Neurosci. Lett. 385 (2005) 158-162
-
(2005)
Neurosci. Lett.
, vol.385
, pp. 158-162
-
-
Costa-Mallen, P.1
Costa, L.G.2
Checkoway, H.3
-
74
-
-
0037328403
-
Monoamine oxidase polymorphisms and smoking behaviour in Japanese
-
Ito H., Hamajima N., Matsuo K., Okuma K., Sato S., Ueda R., and Tajima K. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics 13 (2003) 73-79
-
(2003)
Pharmacogenetics
, vol.13
, pp. 73-79
-
-
Ito, H.1
Hamajima, N.2
Matsuo, K.3
Okuma, K.4
Sato, S.5
Ueda, R.6
Tajima, K.7
-
75
-
-
21244474712
-
Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence
-
Ma J.Z., Beuten J., Payne T.J., Dupont R.T., Elston R.C., and Li M.D. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum. Mol. Genet. 14 (2005) 1691-1698
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 1691-1698
-
-
Ma, J.Z.1
Beuten, J.2
Payne, T.J.3
Dupont, R.T.4
Elston, R.C.5
Li, M.D.6
-
76
-
-
33745591389
-
Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans
-
Yu Y., Panhuysen C., Kranzler H.R., Hesselbrock V., Rounsaville B., Weiss R., Brady K., Farrer L.A., and Gelernter J. Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. Hum. Mol. Genet. 15 (2006) 2192-2199
-
(2006)
Hum. Mol. Genet.
, vol.15
, pp. 2192-2199
-
-
Yu, Y.1
Panhuysen, C.2
Kranzler, H.R.3
Hesselbrock, V.4
Rounsaville, B.5
Weiss, R.6
Brady, K.7
Farrer, L.A.8
Gelernter, J.9
-
77
-
-
33845904424
-
DOPA decarboxylase gene is associated with nicotine dependence
-
Zhang H., Ye Y., Wang X., Gelernter J., Ma J.Z., and Li M.D. DOPA decarboxylase gene is associated with nicotine dependence. Pharmacogenomics 7 (2006) 1159-1166
-
(2006)
Pharmacogenomics
, vol.7
, pp. 1159-1166
-
-
Zhang, H.1
Ye, Y.2
Wang, X.3
Gelernter, J.4
Ma, J.Z.5
Li, M.D.6
-
78
-
-
17644405816
-
Single- and multilocus allelic variants within GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence
-
Beuten J., Ma J.Z., Payne T.J., Dupont R.T., Crews K.M., Somes G., Williams N.J., Elston R.C., and Li M.D. Single- and multilocus allelic variants within GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am. J. Hum. Genet. 76 (2005) 859-864
-
(2005)
Am. J. Hum. Genet.
, vol.76
, pp. 859-864
-
-
Beuten, J.1
Ma, J.Z.2
Payne, T.J.3
Dupont, R.T.4
Crews, K.M.5
Somes, G.6
Williams, N.J.7
Elston, R.C.8
Li, M.D.9
-
79
-
-
20644431788
-
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women
-
Colilla S., Lerman C., Shields P.G., Jepson C., Rukstalis M., Berlin J., DeMichele A., Bunin G., Strom B.L., and Rebbeck T.R. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet. Genomics 15 (2005) 393-398
-
(2005)
Pharmacogenet. Genomics
, vol.15
, pp. 393-398
-
-
Colilla, S.1
Lerman, C.2
Shields, P.G.3
Jepson, C.4
Rukstalis, M.5
Berlin, J.6
DeMichele, A.7
Bunin, G.8
Strom, B.L.9
Rebbeck, T.R.10
-
80
-
-
33846811403
-
Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers
-
Guo S., Chen da F., Zhou D.F., Sun H.Q., Wu G.Y., Haile C.N., Kosten T.A., Kosten T.R., and Zhang X.Y. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology (Berl.) 190 (2007) 449-456
-
(2007)
Psychopharmacology (Berl.)
, vol.190
, pp. 449-456
-
-
Guo, S.1
Chen da, F.2
Zhou, D.F.3
Sun, H.Q.4
Wu, G.Y.5
Haile, C.N.6
Kosten, T.A.7
Kosten, T.R.8
Zhang, X.Y.9
-
81
-
-
20444362730
-
Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results
-
Redden D.T., Shields P.G., Epstein L., Wileyto E.P., Zakharkin S.O., Allison D.B., and Lerman C. Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1384-1389
-
(2005)
Cancer Epidemiol. Biomarkers Prev.
, vol.14
, pp. 1384-1389
-
-
Redden, D.T.1
Shields, P.G.2
Epstein, L.3
Wileyto, E.P.4
Zakharkin, S.O.5
Allison, D.B.6
Lerman, C.7
-
82
-
-
0036260343
-
No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation
-
David S.P., Johnstone E., Griffiths S.E., Murphy M., Yudkin P., Mant D., and Walton R. No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics 12 (2002) 265-268
-
(2002)
Pharmacogenetics
, vol.12
, pp. 265-268
-
-
David, S.P.1
Johnstone, E.2
Griffiths, S.E.3
Murphy, M.4
Yudkin, P.5
Mant, D.6
Walton, R.7
-
83
-
-
0035828112
-
Tryptophan hydroxylase gene variant and smoking behavior
-
Lerman C., Caporaso N.E., Bush A., Zheng Y.L., Audrain J., Main D., and Shields P.G. Tryptophan hydroxylase gene variant and smoking behavior. Am. J. Med. Genet. 105 (2001) 518-520
-
(2001)
Am. J. Med. Genet.
, vol.105
, pp. 518-520
-
-
Lerman, C.1
Caporaso, N.E.2
Bush, A.3
Zheng, Y.L.4
Audrain, J.5
Main, D.6
Shields, P.G.7
-
84
-
-
4143065987
-
Association between smoking habits and tryptophan hydroxylase gene C218A polymorphism among the Japanese population
-
Mizuno S., Ito H., Hamajima N., Tamakoshi A., Hirose K., and Tajima K. Association between smoking habits and tryptophan hydroxylase gene C218A polymorphism among the Japanese population. J. Epidemiol. 14 (2004) 94-99
-
(2004)
J. Epidemiol.
, vol.14
, pp. 94-99
-
-
Mizuno, S.1
Ito, H.2
Hamajima, N.3
Tamakoshi, A.4
Hirose, K.5
Tajima, K.6
-
85
-
-
0035827824
-
Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence
-
Sullivan P.F., Jiang Y., Neale M.C., Kendler K.S., and Straub R.E. Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. Am. J. Med. Genet. 105 (2001) 479-484
-
(2001)
Am. J. Med. Genet.
, vol.105
, pp. 479-484
-
-
Sullivan, P.F.1
Jiang, Y.2
Neale, M.C.3
Kendler, K.S.4
Straub, R.E.5
-
86
-
-
0034011863
-
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior
-
Hu S., Brody C.L., Fisher C., Gunzerath L., Nelson M.L., Sabol S.Z., Sirota L.A., Marcus S.E., Greenberg B.D., Murphy D.L., and Hamer D.H. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol. Psychiatry 5 (2000) 181-188
-
(2000)
Mol. Psychiatry
, vol.5
, pp. 181-188
-
-
Hu, S.1
Brody, C.L.2
Fisher, C.3
Gunzerath, L.4
Nelson, M.L.5
Sabol, S.Z.6
Sirota, L.A.7
Marcus, S.E.8
Greenberg, B.D.9
Murphy, D.L.10
Hamer, D.H.11
-
87
-
-
0034056121
-
Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence
-
Lerman C., Caporaso N.E., Audrain J., Main D., Boyd N.R., and Shields P.G. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol. Psychiatry 5 (2000) 189-192
-
(2000)
Mol. Psychiatry
, vol.5
, pp. 189-192
-
-
Lerman, C.1
Caporaso, N.E.2
Audrain, J.3
Main, D.4
Boyd, N.R.5
Shields, P.G.6
-
88
-
-
0031926726
-
The role of the serotonin transporter gene in cigarette smoking
-
Lerman C., Shields P., Audrain J., Main D., Cobb B., Boyd N., and Caparoso N. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 253-255
-
(1998)
Cancer Epidemiol. Biomarkers Prev.
, vol.7
, pp. 253-255
-
-
Lerman, C.1
Shields, P.2
Audrain, J.3
Main, D.4
Cobb, B.5
Boyd, N.6
Caparoso, N.7
-
89
-
-
0032830295
-
Association between serotonin transporter gene polymorphism and smoking among Japanese males
-
Ishikawa H., Ohtsuki T., Ishiguro H., Yamakawa-Kobayashi K., Endo K., Lin Y.L., Yanagi H., Tsuchiya S., Kawata K., Hamaguchi H., and Arinami T. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 831-833
-
(1999)
Cancer Epidemiol. Biomarkers Prev.
, vol.8
, pp. 831-833
-
-
Ishikawa, H.1
Ohtsuki, T.2
Ishiguro, H.3
Yamakawa-Kobayashi, K.4
Endo, K.5
Lin, Y.L.6
Yanagi, H.7
Tsuchiya, S.8
Kawata, K.9
Hamaguchi, H.10
Arinami, T.11
-
90
-
-
1342266758
-
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch
-
Johnstone E.C., Yudkin P.L., Hey K., Roberts S.J., Welch S.J., Murphy M.F., Griffiths S.E., and Walton R.T. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenet. Genomics 14 (2004) 83-90
-
(2004)
Pharmacogenet. Genomics
, vol.14
, pp. 83-90
-
-
Johnstone, E.C.1
Yudkin, P.L.2
Hey, K.3
Roberts, S.J.4
Welch, S.J.5
Murphy, M.F.6
Griffiths, S.E.7
Walton, R.T.8
-
91
-
-
2942738811
-
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial
-
Lerman C., Wileyto E.P., Patterson F., Rukstalis M., Audrain-McGovern J., Restine S., Shields P.G., Kaufmann V., Redden D., Benowitz N., and Berrettini W.H. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J. 4 (2004) 184-192
-
(2004)
Pharmacogenomics J.
, vol.4
, pp. 184-192
-
-
Lerman, C.1
Wileyto, E.P.2
Patterson, F.3
Rukstalis, M.4
Audrain-McGovern, J.5
Restine, S.6
Shields, P.G.7
Kaufmann, V.8
Redden, D.9
Benowitz, N.10
Berrettini, W.H.11
-
92
-
-
1942436021
-
Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial
-
Yudkin P., Munafo M., Hey K., Roberts S., Welch S., Johnstone E., Murphy M., Griffiths S., and Walton R. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 328 (2004) 989-990
-
(2004)
BMJ
, vol.328
, pp. 989-990
-
-
Yudkin, P.1
Munafo, M.2
Hey, K.3
Roberts, S.4
Welch, S.5
Johnstone, E.6
Murphy, M.7
Griffiths, S.8
Walton, R.9
-
93
-
-
33744524335
-
Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting responses to nicotine replacement therapy for tobacco dependence
-
Dahl J.P., Jepson C., Levenson R., Wileyto E.P., Patterson F., Berrettini W.H., and Lerman C. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting responses to nicotine replacement therapy for tobacco dependence. Pharmacogenomics J. 6 (2006) 194-199
-
(2006)
Pharmacogenomics J.
, vol.6
, pp. 194-199
-
-
Dahl, J.P.1
Jepson, C.2
Levenson, R.3
Wileyto, E.P.4
Patterson, F.5
Berrettini, W.H.6
Lerman, C.7
-
94
-
-
33744519035
-
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation
-
Lerman C., Tyndale R., Patterson F., Wileyto E.P., Shields P.G., Pinto A., and Benowitz N. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin. Pharmacol. Ther. 79 (2006) 600-608
-
(2006)
Clin. Pharmacol. Ther.
, vol.79
, pp. 600-608
-
-
Lerman, C.1
Tyndale, R.2
Patterson, F.3
Wileyto, E.P.4
Shields, P.G.5
Pinto, A.6
Benowitz, N.7
-
95
-
-
32844456518
-
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials
-
Lerman C., Jepson C., Wileyto E.P., Epstein L.H., Rukstalis M., Patterson F., Kaufmann V., Restine S., Hawk L., Niaura R., and Berrettini W. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 31 (2006) 231-242
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 231-242
-
-
Lerman, C.1
Jepson, C.2
Wileyto, E.P.3
Epstein, L.H.4
Rukstalis, M.5
Patterson, F.6
Kaufmann, V.7
Restine, S.8
Hawk, L.9
Niaura, R.10
Berrettini, W.11
-
96
-
-
33645525613
-
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from usage of nicotine replacement therapy
-
Malaiyandi V., Lerman C., Benowitz N.L., Jepson C., Patterson F., and Tyndale R.F. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from usage of nicotine replacement therapy. Mol. Psychiatry 11 (2006) 400-409
-
(2006)
Mol. Psychiatry
, vol.11
, pp. 400-409
-
-
Malaiyandi, V.1
Lerman, C.2
Benowitz, N.L.3
Jepson, C.4
Patterson, F.5
Tyndale, R.F.6
-
97
-
-
33644770974
-
Lack of assocation of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial
-
Munafò M.R., Johnstone E.C., Wileyto E.P., Shields P.G., Elliot K.M., and Lerman C. Lack of assocation of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 398-400
-
(2006)
Cancer Epidemiol. Biomarkers Prev.
, vol.15
, pp. 398-400
-
-
Munafò, M.R.1
Johnstone, E.C.2
Wileyto, E.P.3
Shields, P.G.4
Elliot, K.M.5
Lerman, C.6
-
98
-
-
40949133385
-
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clicinal trial of transdermal nicotine patch
-
David S.P., Munafo M.R., Murphy M.F., Proctor M., Walton R.T., and Johnstone E.C. Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clicinal trial of transdermal nicotine patch. Pharmacogenomics J. 8 (2008) 122-128
-
(2008)
Pharmacogenomics J.
, vol.8
, pp. 122-128
-
-
David, S.P.1
Munafo, M.R.2
Murphy, M.F.3
Proctor, M.4
Walton, R.T.5
Johnstone, E.C.6
-
99
-
-
34047205168
-
The serotonin transporter 5-HTTLPR polymorhism and treatment response to nicotine patch: follow-up of a randomized controlled trial
-
David S.P., Munafo M., Murphy M.F.G., Walton R.T., and Johnstone E.C. The serotonin transporter 5-HTTLPR polymorhism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob. Res. 9 (2007) 225-231
-
(2007)
Nicotine Tob. Res.
, vol.9
, pp. 225-231
-
-
David, S.P.1
Munafo, M.2
Murphy, M.F.G.3
Walton, R.T.4
Johnstone, E.C.5
-
100
-
-
34548405100
-
CHRNA4 and tobacco dependence. From gene regulation to treatment outcome
-
Hutchison K.E., Allen D.L., Filbey F.M., Jepson C., Lerman C., Benowitz N., Stitzel J., Bryan A., McGeary J., and Haughey H.M. CHRNA4 and tobacco dependence. From gene regulation to treatment outcome. Arch. Gen. Psychiatry 64 (2007) 1078-1086
-
(2007)
Arch. Gen. Psychiatry
, vol.64
, pp. 1078-1086
-
-
Hutchison, K.E.1
Allen, D.L.2
Filbey, F.M.3
Jepson, C.4
Lerman, C.5
Benowitz, N.6
Stitzel, J.7
Bryan, A.8
McGeary, J.9
Haughey, H.M.10
-
101
-
-
34250861376
-
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial
-
Johnstone E.C., Elliot K.M., David S.P., Murphy M.F.G., Walton R.T., and Munafo M.R. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1065-1069
-
(2007)
Cancer Epidemiol. Biomarkers Prev.
, vol.16
, pp. 1065-1069
-
-
Johnstone, E.C.1
Elliot, K.M.2
David, S.P.3
Murphy, M.F.G.4
Walton, R.T.5
Munafo, M.R.6
-
102
-
-
34250841276
-
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy
-
Lee A.M., Jepson C., Shields P.G., Benowitz N., Lerman C., and Tyndale R.F. CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1312-1314
-
(2007)
Cancer Epidemiol. Biomarkers Prev.
, vol.16
, pp. 1312-1314
-
-
Lee, A.M.1
Jepson, C.2
Shields, P.G.3
Benowitz, N.4
Lerman, C.5
Tyndale, R.F.6
-
103
-
-
33847756897
-
Association of the mu-opioid receptor gene with smoking cessation
-
Munafò M.R., Elliot K.M., Murphy M.F., Walton R.T., and Johnstone E.C. Association of the mu-opioid receptor gene with smoking cessation. Pharmacogenomics J. 7 (2007) 353-361
-
(2007)
Pharmacogenomics J.
, vol.7
, pp. 353-361
-
-
Munafò, M.R.1
Elliot, K.M.2
Murphy, M.F.3
Walton, R.T.4
Johnstone, E.C.5
-
104
-
-
33846564325
-
Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment
-
O'Gara C., Stapleton J., Sutherland G., Guindalini C., Neale B., Breen G., and Ball D. Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. Pharmacogenet. Genomics 17 (2007) 61-67
-
(2007)
Pharmacogenet. Genomics
, vol.17
, pp. 61-67
-
-
O'Gara, C.1
Stapleton, J.2
Sutherland, G.3
Guindalini, C.4
Neale, B.5
Breen, G.6
Ball, D.7
-
105
-
-
35248821416
-
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial
-
Ray R., Jepson C., Wileyto E.P., Dahl J.P., Patterson F., Rukstalis M., Pinto A., Berrettini W., and Lerman C. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine Tob. Res. 9 (2007) 1237-1241
-
(2007)
Nicotine Tob. Res.
, vol.9
, pp. 1237-1241
-
-
Ray, R.1
Jepson, C.2
Wileyto, E.P.3
Dahl, J.P.4
Patterson, F.5
Rukstalis, M.6
Pinto, A.7
Berrettini, W.8
Lerman, C.9
-
106
-
-
38149079868
-
Association of COMT Val108/158Met genotype with smoking cessation
-
Munafò M.R., Johnstone E.C., Guo B., Murphy M.F., and Aveyard P. Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet. Genomics 18 (2008) 121-128
-
(2008)
Pharmacogenet. Genomics
, vol.18
, pp. 121-128
-
-
Munafò, M.R.1
Johnstone, E.C.2
Guo, B.3
Murphy, M.F.4
Aveyard, P.5
-
107
-
-
12244267745
-
Pharmacogenetic investigation of smoking cessation treatment
-
Lerman C., Shields P.G., Wileyto E.P., Audrain J., Pinto A., Hawk L., Krishnan S., Niaura R., and Epstein L. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 12 (2002) 627-634
-
(2002)
Pharmacogenetics
, vol.12
, pp. 627-634
-
-
Lerman, C.1
Shields, P.G.2
Wileyto, E.P.3
Audrain, J.4
Pinto, A.5
Hawk, L.6
Krishnan, S.7
Niaura, R.8
Epstein, L.9
-
108
-
-
9144252813
-
Does the DRD2-Taq1 A polymorphism influence treatment response to buproprion hydrochloride for reduction of the nicotine withdrawal syndrome?
-
David S.P., Niaura R., Papandonatos G.D., Shadel W.G., Burkholder G.J., Britt D.M., Day A., Stumpff J., Hutchison K., Murphy M., Johnstone E., Griffiths S.E., and Walton R.T. Does the DRD2-Taq1 A polymorphism influence treatment response to buproprion hydrochloride for reduction of the nicotine withdrawal syndrome?. Nicotine Tob. Res. 5 (2003) 935-942
-
(2003)
Nicotine Tob. Res.
, vol.5
, pp. 935-942
-
-
David, S.P.1
Niaura, R.2
Papandonatos, G.D.3
Shadel, W.G.4
Burkholder, G.J.5
Britt, D.M.6
Day, A.7
Stumpff, J.8
Hutchison, K.9
Murphy, M.10
Johnstone, E.11
Griffiths, S.E.12
Walton, R.T.13
-
109
-
-
10744220811
-
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial
-
Lerman C., Shields P.G., Wileyto E.P., Audrain J., Hawk L.H.J., Pinto A., Kucharski S., Krishnan S., Niaura R., and Epstein L.H. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol. 22 (2003) 541-548
-
(2003)
Health Psychol.
, vol.22
, pp. 541-548
-
-
Lerman, C.1
Shields, P.G.2
Wileyto, E.P.3
Audrain, J.4
Hawk, L.H.J.5
Pinto, A.6
Kucharski, S.7
Krishnan, S.8
Niaura, R.9
Epstein, L.H.10
-
110
-
-
13544268694
-
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR
-
Swan G.E., Valdes A.M., Ring H.Z., Khroyan T.V., Jack L.M., Ton C.C., Curry S.J., and McAfee T. Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. Pharmacogenomics J. 5 (2005) 21-29
-
(2005)
Pharmacogenomics J.
, vol.5
, pp. 21-29
-
-
Swan, G.E.1
Valdes, A.M.2
Ring, H.Z.3
Khroyan, T.V.4
Jack, L.M.5
Ton, C.C.6
Curry, S.J.7
McAfee, T.8
-
111
-
-
33845197186
-
Catechol-O-Methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence
-
Berrettini W.H., Wileyto E.P., Epstein L., Restine S., Hawk L., Shields P., Niaura R., and Lerman C. Catechol-O-Methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol. Psychiatry 61 (2007) 111-118
-
(2007)
Biol. Psychiatry
, vol.61
, pp. 111-118
-
-
Berrettini, W.H.1
Wileyto, E.P.2
Epstein, L.3
Restine, S.4
Hawk, L.5
Shields, P.6
Niaura, R.7
Lerman, C.8
-
112
-
-
36749060044
-
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials
-
David S.P., Strong D.R., Munafò M.R., Brown R.A., Lloyd-Richardson E.E., Wileyto E.P., Evins E.A., Shields P.G., Lerman C., and Niaura R. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob. Res. 9 (2007) 1251-1257
-
(2007)
Nicotine Tob. Res.
, vol.9
, pp. 1251-1257
-
-
David, S.P.1
Strong, D.R.2
Munafò, M.R.3
Brown, R.A.4
Lloyd-Richardson, E.E.5
Wileyto, E.P.6
Evins, E.A.7
Shields, P.G.8
Lerman, C.9
Niaura, R.10
-
113
-
-
34248521145
-
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation
-
David S.P., Brown R.A., Papandonatos G.D., Kahler C.W., Lloyd-Richardson E.E., Munafo M.R., Shields P.G., Lerman C., Strong D., McCaffery J., and Niaura R. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob. Res. 9 (2007) 821-833
-
(2007)
Nicotine Tob. Res.
, vol.9
, pp. 821-833
-
-
David, S.P.1
Brown, R.A.2
Papandonatos, G.D.3
Kahler, C.W.4
Lloyd-Richardson, E.E.5
Munafo, M.R.6
Shields, P.G.7
Lerman, C.8
Strong, D.9
McCaffery, J.10
Niaura, R.11
-
114
-
-
33847708868
-
CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial
-
Lee A.M., Jepson C., Hoffmann E., Epstein L., Hawk L.W., Lerman C., and Tyndale R.F. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol. Psychiatry 62 (2007) 635-641
-
(2007)
Biol. Psychiatry
, vol.62
, pp. 635-641
-
-
Lee, A.M.1
Jepson, C.2
Hoffmann, E.3
Epstein, L.4
Hawk, L.W.5
Lerman, C.6
Tyndale, R.F.7
-
115
-
-
34248594556
-
Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR
-
Swan G.E., Jack L.M., Valdes A.M., Ring H.Z., Ton C.C., Curry S.J., and McAfee T. Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR. Health Psychol. 26 (2007) 361-368
-
(2007)
Health Psychol.
, vol.26
, pp. 361-368
-
-
Swan, G.E.1
Jack, L.M.2
Valdes, A.M.3
Ring, H.Z.4
Ton, C.C.5
Curry, S.J.6
McAfee, T.7
-
116
-
-
2542495997
-
The effects of the DRD2 polymorphism on smoking cessation and negative effect: evidence for a pharmacogenetic effect on mood
-
Cinciripini P.M., Wetter D.W., Tomlinson G.E., Tsoh J.Y., De Moor C.A., Cinciripini L.G., and Minna J. The effects of the DRD2 polymorphism on smoking cessation and negative effect: evidence for a pharmacogenetic effect on mood. Nicotine Tob. Res. 6 (2004) 229-239
-
(2004)
Nicotine Tob. Res.
, vol.6
, pp. 229-239
-
-
Cinciripini, P.M.1
Wetter, D.W.2
Tomlinson, G.E.3
Tsoh, J.Y.4
De Moor, C.A.5
Cinciripini, L.G.6
Minna, J.7
-
117
-
-
34248597543
-
Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: abstinence and withdrawal symptoms
-
Munafò M.R., and Johnstone E.C. Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: abstinence and withdrawal symptoms. Pharmacogenomics J. 8 (2007) 513-517
-
(2007)
Pharmacogenomics J.
, vol.8
, pp. 513-517
-
-
Munafò, M.R.1
Johnstone, E.C.2
-
118
-
-
34547626815
-
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms
-
Robinson J.D., Lam C.Y., Minnix J.A., Wetter D.W., Tomlinson G.E., Minna J.D., Chen T.T., and Cinciripini P.M. The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogenomics J. 7 (2007) 266-274
-
(2007)
Pharmacogenomics J.
, vol.7
, pp. 266-274
-
-
Robinson, J.D.1
Lam, C.Y.2
Minnix, J.A.3
Wetter, D.W.4
Tomlinson, G.E.5
Minna, J.D.6
Chen, T.T.7
Cinciripini, P.M.8
-
119
-
-
34247847781
-
Cholecystokinin C-45T polymorphism and smoking cessation in women
-
Ton T.G., Rossing M.A., Bowen D.J., Wilkerson H.-W., and Farin F.M. Cholecystokinin C-45T polymorphism and smoking cessation in women. Nicotine Tob. Res. 9 (2007) 147-151
-
(2007)
Nicotine Tob. Res.
, vol.9
, pp. 147-151
-
-
Ton, T.G.1
Rossing, M.A.2
Bowen, D.J.3
Wilkerson, H.-W.4
Farin, F.M.5
-
120
-
-
34547220462
-
Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study
-
Ton T.G.N., Rossing M.A., Bowen D.J., Srinouanprachan S., Wicklund K., and Farin F.M. Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study. Behav. Brain Funct. 3 (2007) 22
-
(2007)
Behav. Brain Funct.
, vol.3
, pp. 22
-
-
Ton, T.G.N.1
Rossing, M.A.2
Bowen, D.J.3
Srinouanprachan, S.4
Wicklund, K.5
Farin, F.M.6
-
121
-
-
33748642570
-
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine
-
Ray R., Jepson C., Patterson F., Strasser A., Rukstalis M., Perkins K., Lynch K.G., O'Malley S., Berrettini W.H., and Lerman C. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Pscyhopharmacology (Berl.) 188 (2006) 355-363
-
(2006)
Pscyhopharmacology (Berl.)
, vol.188
, pp. 355-363
-
-
Ray, R.1
Jepson, C.2
Patterson, F.3
Strasser, A.4
Rukstalis, M.5
Perkins, K.6
Lynch, K.G.7
O'Malley, S.8
Berrettini, W.H.9
Lerman, C.10
-
122
-
-
28244490238
-
Lack of effect of D2 dopamine receptor Taq1A polymorphisms on smoking cessation
-
Berlin I., Covey L.S., Jiang H., and Hamer D. Lack of effect of D2 dopamine receptor Taq1A polymorphisms on smoking cessation. Nicotine Tob. Res. 7 (2005) 725-728
-
(2005)
Nicotine Tob. Res.
, vol.7
, pp. 725-728
-
-
Berlin, I.1
Covey, L.S.2
Jiang, H.3
Hamer, D.4
-
123
-
-
22244451365
-
The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans
-
Park H.J., Kim S.T., Yoon D.H., Jin S.H., Lee S.J., Lee H.J., and Lim S. The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans. J. Altern. Complement. Med. 11 (2005) 401-405
-
(2005)
J. Altern. Complement. Med.
, vol.11
, pp. 401-405
-
-
Park, H.J.1
Kim, S.T.2
Yoon, D.H.3
Jin, S.H.4
Lee, S.J.5
Lee, H.J.6
Lim, S.7
-
124
-
-
0027156661
-
Effectiveness of a nicotine patch in helping people stop smoking: Results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group
-
Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group. BMJ 306 (1993) 1304-1308.
-
(1993)
BMJ
, vol.306
, pp. 1304-1308
-
-
-
125
-
-
0028240219
-
Randomised trial of nicotine patches in general practice: Results at one year. Imperial Cancer Research Fund General Practice Research Group
-
Randomised trial of nicotine patches in general practice: results at one year. Imperial Cancer Research Fund General Practice Research Group. BMJ 308 (1994) 1476-1477.
-
(1994)
BMJ
, vol.308
, pp. 1476-1477
-
-
-
126
-
-
1542298180
-
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial
-
Lerman C., Kaufmann V., Rukstalis M., Patterson F., Perkins K., Audrain-McGovern J., and Benowitz N. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann. Intern. Med. 140 (2004) 426-433
-
(2004)
Ann. Intern. Med.
, vol.140
, pp. 426-433
-
-
Lerman, C.1
Kaufmann, V.2
Rukstalis, M.3
Patterson, F.4
Perkins, K.5
Audrain-McGovern, J.6
Benowitz, N.7
-
127
-
-
8044258385
-
Role of human cytochrome P4502A6 in C-oxidation of nicotine
-
Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., and Kuroiwa Y. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab. Dispos. 24 (1996) 1212-1217
-
(1996)
Drug Metab. Dispos.
, vol.24
, pp. 1212-1217
-
-
Nakajima, M.1
Yamamoto, T.2
Nunoya, K.3
Yokoi, T.4
Nagashima, K.5
Inoue, K.6
Funae, Y.7
Shimada, N.8
Kamataki, T.9
Kuroiwa, Y.10
-
128
-
-
0030885491
-
A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes
-
Messina E.S., Tyndale R.F., and Sellers E.M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J. Pharmacol. Exp. Ther. 282 (1997) 1608-1614
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.282
, pp. 1608-1614
-
-
Messina, E.S.1
Tyndale, R.F.2
Sellers, E.M.3
-
129
-
-
67649360943
-
-
Cytochrome P450 (CYP) Allele Nomenclature Committee. CYP2A6 Allele Nomenclature website (Accessed on 2008 August 15). Available from: http://www.cypalleles.ki.se/cyp2a6.htm.
-
Cytochrome P450 (CYP) Allele Nomenclature Committee. CYP2A6 Allele Nomenclature website (Accessed on 2008 August 15). Available from: http://www.cypalleles.ki.se/cyp2a6.htm.
-
-
-
-
130
-
-
0036499938
-
Nicotine addiction: the possible role of functional upregulation
-
Buisson B., and Bertrand D. Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol. Sci. 23 (2002) 130-136
-
(2002)
Trends Pharmacol. Sci.
, vol.23
, pp. 130-136
-
-
Buisson, B.1
Bertrand, D.2
-
131
-
-
2642572803
-
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1
-
Neville M.J., Johnstone E.C., and Walton R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum. Mutat. 23 (2004) 540-545
-
(2004)
Hum. Mutat.
, vol.23
, pp. 540-545
-
-
Neville, M.J.1
Johnstone, E.C.2
Walton, R.T.3
-
132
-
-
12344328265
-
An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk
-
Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., and Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin. Exp. Res. 29 (2005) 8-16
-
(2005)
Alcohol Clin. Exp. Res.
, vol.29
, pp. 8-16
-
-
Hu, X.1
Oroszi, G.2
Chun, J.3
Smith, T.L.4
Goldman, D.5
Schuckit, M.A.6
-
133
-
-
0028787766
-
Bupropion: a review of its mechanism of antidepressant activity
-
Ascher J.A., Cole J.O., Colin J.N., Feighner J.P., Ferris R.M., Fibiger H.C., Golden R.N., Martin P., Potter W.Z., Richelson E., and Sulser F. Bupropion: a review of its mechanism of antidepressant activity. J. Clin. Psychiatry 56 (1995) 395-401
-
(1995)
J. Clin. Psychiatry
, vol.56
, pp. 395-401
-
-
Ascher, J.A.1
Cole, J.O.2
Colin, J.N.3
Feighner, J.P.4
Ferris, R.M.5
Fibiger, H.C.6
Golden, R.N.7
Martin, P.8
Potter, W.Z.9
Richelson, E.10
Sulser, F.11
-
134
-
-
0032981063
-
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
-
Sanchez C., and Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 19 (1999) 467-489
-
(1999)
Cell. Mol. Neurobiol.
, vol.19
, pp. 467-489
-
-
Sanchez, C.1
Hyttel, J.2
-
135
-
-
0036644499
-
Mediating mechanisms for the impact of bupropion in smoking cessation treatment
-
Lerman C., Roth D., Kaufmann V., Audrain J., Hawk L., Liu A., Niaura R., and Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend. 67 (2002) 219-223
-
(2002)
Drug Alcohol Depend.
, vol.67
, pp. 219-223
-
-
Lerman, C.1
Roth, D.2
Kaufmann, V.3
Audrain, J.4
Hawk, L.5
Liu, A.6
Niaura, R.7
Epstein, L.8
-
136
-
-
0037403030
-
Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting
-
Jack L.M., Swan G.E., Thompson E., Curry S.J., McAfee T., Dacey S., and Bergman K. Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting. Prev. Med. 36 (2003) 585-593
-
(2003)
Prev. Med.
, vol.36
, pp. 585-593
-
-
Jack, L.M.1
Swan, G.E.2
Thompson, E.3
Curry, S.J.4
McAfee, T.5
Dacey, S.6
Bergman, K.7
-
137
-
-
0142150148
-
Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial
-
Swan G.E., McAfee T., Curry S.J., Jack L.M., Javitz H., Dacey S., and Bergman K. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch. Intern. Med. 163 (2003) 2337-2344
-
(2003)
Arch. Intern. Med.
, vol.163
, pp. 2337-2344
-
-
Swan, G.E.1
McAfee, T.2
Curry, S.J.3
Jack, L.M.4
Javitz, H.5
Dacey, S.6
Bergman, K.7
-
138
-
-
34347337567
-
Bupropion and cognitive-behavioral treatment for depression in smoking cessation
-
Brown R.A., Niaura R., Lloyd-Richardson E.E., Strong D.R., Kahler C.W., Abrantes A.M., Abrams D., and Miller I.W. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob. Res. 9 (2007) 721-730
-
(2007)
Nicotine Tob. Res.
, vol.9
, pp. 721-730
-
-
Brown, R.A.1
Niaura, R.2
Lloyd-Richardson, E.E.3
Strong, D.R.4
Kahler, C.W.5
Abrantes, A.M.6
Abrams, D.7
Miller, I.W.8
|